{
    "abstract": "Malaria transmission blocking (TB) vaccines (TBVs) directed against proteins expressed on the sexual stages of Plasmodium parasites are a potentially effective means to reduce transmission. Antibodies induced by TBVs block parasite development in the mosquito, and thus inhibit transmission to further human hosts. The ookinete surface protein P25 is a primary target for TBV development. Recently, transient expression in plants using hybrid viral vectors has demonstrated potential as a strategy for cost-effective and scalable production of recombinant vaccines. Using a plant virus-based expression system, we produced recombinant P25 protein of Plasmodium vivax (Pvs25) in Nicotiana benthamiana fused to a modified lichenase carrier protein. This candidate vaccine, Pvs25-FhCMB, was purified, characterized and evaluated for immunogenicity and efficacy using multiple adjuvants in a transgenic rodent model. An in vivo TB effect of up to a 65% reduction in intensity and 54% reduction in prevalence was observed using Abisco-100 adjuvant. The ability of this immunogen to induce a TB response was additionally combined with heterologous prime-boost vaccination with viral vectors expressing Pvs25. Significant blockade was observed when combining both platforms, achieving a 74% and 68% reduction in intensity and prevalence, respectively. This observation was confirmed by direct membrane feeding on field P. vivax samples, resulting in reductions in intensity/prevalence of 85.3% and 25.5%. These data demonstrate the potential of this vaccine candidate and support the feasibility of expressing Plasmodium antigens in a plant-based system for the production of TBVs, while demonstrating the potential advantages of combining multiple vaccine delivery systems to maximize efficacy.",
    "bib_entries": {
        "bib0250": null,
        "bib0255": null,
        "bib0260": {
            "authors": [
                {
                    "first": "Ivo",
                    "initial": "I.",
                    "last": "Mueller"
                },
                {
                    "first": "Mary R.",
                    "initial": "M.R.",
                    "last": "Galinski"
                },
                {
                    "first": "J. Kevin",
                    "initial": "J.K.",
                    "last": "Baird"
                },
                {
                    "first": "Jane M.",
                    "initial": "J.M.",
                    "last": "Carlton"
                },
                {
                    "first": "Dhanpat K.",
                    "initial": "D.K.",
                    "last": "Kochar"
                },
                {
                    "first": "Pedro L.",
                    "initial": "P.L.",
                    "last": "Alonso"
                },
                {
                    "first": "Hernando A.",
                    "initial": "H.A.",
                    "last": "del Portillo"
                }
            ],
            "doi": "10.1016/S1473-3099(09)70177-X",
            "firstpage": "555",
            "issn": "14733099",
            "lastpage": "566",
            "pmid": "19695492",
            "pub_year": 2009,
            "title": "Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite",
            "volume": "9"
        },
        "bib0265": null,
        "bib0270": {
            "authors": [
                {
                    "first": "Ric N.",
                    "initial": "R.N.",
                    "last": "Price"
                },
                {
                    "first": "Lorenz",
                    "initial": "L.",
                    "last": "von Seidlein"
                },
                {
                    "first": "Neena",
                    "initial": "N.",
                    "last": "Valecha"
                },
                {
                    "first": "Francois",
                    "initial": "F.",
                    "last": "Nosten"
                },
                {
                    "first": "J. Kevin",
                    "initial": "J.K.",
                    "last": "Baird"
                },
                {
                    "first": "Nicholas J.",
                    "initial": "N.J.",
                    "last": "White"
                }
            ],
            "doi": "10.1016/S1473-3099(14)70855-2",
            "firstpage": "982",
            "issn": "14733099",
            "lastpage": "991",
            "pmid": "25213732",
            "pub_year": 2014,
            "title": "Global extent of chloroquine-resistant Plasmodium vivax: A systematic review and meta-analysis",
            "volume": "14"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Jonathan A.",
                    "initial": "J.A.",
                    "last": "Patz"
                },
                {
                    "first": "Sarah H.",
                    "initial": "S.H.",
                    "last": "Olson"
                }
            ],
            "doi": "10.1073/pnas.0601493103",
            "firstpage": "5635",
            "issn": "00278424",
            "lastpage": "5636",
            "pmid": "16595623",
            "pub_year": 2006,
            "title": "Malaria risk and temperature: Influences from global climate change and local land use practices",
            "volume": "103"
        },
        "bib0280": {
            "authors": [
                {
                    "first": "Peter W.",
                    "initial": "P.W.",
                    "last": "Gething"
                },
                {
                    "first": "Thomas P.",
                    "initial": "T.P.",
                    "last": "Van Boeckel"
                },
                {
                    "first": "David L.",
                    "initial": "D.L.",
                    "last": "Smith"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Guerra"
                },
                {
                    "first": "Anand P.",
                    "initial": "A.P.",
                    "last": "Patil"
                },
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Snow"
                },
                {
                    "first": "Simon I.",
                    "initial": "S.I.",
                    "last": "Hay"
                }
            ],
            "doi": "10.1186/1756-3305-4-92",
            "issn": "17563305",
            "pmid": "21615906",
            "pub_year": 2011,
            "title": "Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax",
            "volume": "4"
        },
        "bib0285": {
            "authors": [
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1098/rstb.2011.0091",
            "firstpage": "2806",
            "issn": "09628436",
            "lastpage": "2814",
            "pub_year": 2011,
            "title": "Vaccines against malaria",
            "volume": "366"
        },
        "bib0290": {
            "authors": [
                {
                    "first": "Mahamadou A.",
                    "initial": "M.A.",
                    "last": "Thera"
                },
                {
                    "first": "Christopher V.",
                    "initial": "C.V.",
                    "last": "Plowe"
                }
            ],
            "doi": "10.1146/annurev-med-022411-192402",
            "firstpage": "345",
            "issn": "00664219",
            "lastpage": "357",
            "pmid": "22077719",
            "pub_year": 2012,
            "title": "Vaccines for malaria: How close are we?",
            "volume": "63"
        },
        "bib0295": {
            "authors": [
                {
                    "first": null,
                    "initial": null,
                    "last": "The malERA Consultative Group on Vaccines"
                }
            ],
            "doi": "10.1371/journal.pmed.1000398",
            "issn": "15491277",
            "pmid": "21311586",
            "pub_year": 2011,
            "title": "A research agenda for malaria eradication: Vaccines",
            "volume": "8"
        },
        "bib0300": {
            "authors": [
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                },
                {
                    "first": "Ian C.",
                    "initial": "I.C.",
                    "last": "Bathurst"
                },
                {
                    "first": "Philip J.",
                    "initial": "P.J.",
                    "last": "Barr"
                }
            ],
            "doi": "10.1016/0167-7799(92)90280-9",
            "firstpage": "388",
            "issn": "01677799",
            "lastpage": "391",
            "pmid": "1368880",
            "pub_year": 1992,
            "title": "Malaria transmission-blocking vaccines",
            "volume": "10"
        },
        "bib0305": {
            "authors": [
                {
                    "first": "Arno N.",
                    "initial": "A.N.",
                    "last": "Vermeulen"
                },
                {
                    "first": "Thivi",
                    "initial": "T.",
                    "last": "Ponnudurai"
                },
                {
                    "first": "Pieter J.A.",
                    "initial": "P.J.A.",
                    "last": "Beckers"
                },
                {
                    "first": "Jan Peter",
                    "initial": "J.P.",
                    "last": "Verhave"
                },
                {
                    "first": "Mari A.",
                    "initial": "M.A.",
                    "last": "Smits"
                },
                {
                    "first": "Joseph H.E.Th",
                    "initial": "J.H.E.T.",
                    "last": "Meuwissen"
                }
            ],
            "doi": "10.1084/jem.162.5.1460",
            "firstpage": "1460",
            "issn": "00221007",
            "lastpage": "1476",
            "pmid": "2865324",
            "pub_year": 1985,
            "title": "Sequential expression of antigens on sexual stages of plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito",
            "volume": "162"
        },
        "bib0310": {
            "authors": [
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                },
                {
                    "first": "Isabella A.",
                    "initial": "I.A.",
                    "last": "Quakyi"
                },
                {
                    "first": "Chiang",
                    "initial": "C.",
                    "last": "Syin"
                },
                {
                    "first": "Michael G.",
                    "initial": "M.G.",
                    "last": "Raum"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Keister"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Coligan"
                },
                {
                    "first": "Thomas F.",
                    "initial": "T.F.",
                    "last": "McCutchan"
                },
                {
                    "first": "Louis H.",
                    "initial": "L.H.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1038/333074a0",
            "firstpage": "74",
            "issn": "00280836",
            "lastpage": "76",
            "pmid": "3283563",
            "pub_year": 1988,
            "title": "A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains",
            "volume": "333"
        },
        "bib0320": {
            "authors": [
                {
                    "first": "Aaron P.",
                    "initial": "A.P.",
                    "last": "Miles"
                },
                {
                    "first": "Yanling",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Saul"
                },
                {
                    "first": "Anthony W.",
                    "initial": "A.W.",
                    "last": "Stowers"
                }
            ],
            "doi": "10.1006/prep.2001.1613",
            "firstpage": "87",
            "issn": "10465928",
            "lastpage": "96",
            "pmid": "12071703",
            "pub_year": 2002,
            "title": "Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials",
            "volume": "25"
        },
        "bib0325": {
            "authors": [
                {
                    "first": "William E.",
                    "initial": "W.E.",
                    "last": "Collins"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Barnwell"
                },
                {
                    "first": "Joann S.",
                    "initial": "J.S.",
                    "last": "Sullivan"
                },
                {
                    "first": "Douglas",
                    "initial": "D.",
                    "last": "Nace"
                },
                {
                    "first": "Tyrone",
                    "initial": "T.",
                    "last": "Williams"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Bounngaseng"
                },
                {
                    "first": "Jacquelin",
                    "initial": "J.",
                    "last": "Roberts"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Strobert"
                },
                {
                    "first": "Harold",
                    "initial": "H.",
                    "last": "McClure"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Saul"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                }
            ],
            "firstpage": "215",
            "issn": "00029637",
            "lastpage": "221",
            "pmid": "16474073",
            "pub_year": 2006,
            "title": "Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzees",
            "volume": "74"
        },
        "bib0330": {
            "authors": [
                {
                    "first": "Hajime",
                    "initial": "H.",
                    "last": "Hisaeda"
                },
                {
                    "first": "Anthony W.",
                    "initial": "A.W.",
                    "last": "Stowers"
                },
                {
                    "first": "Takafumi",
                    "initial": "T.",
                    "last": "Tsuboi"
                },
                {
                    "first": "William E.",
                    "initial": "W.E.",
                    "last": "Collins"
                },
                {
                    "first": "Jetsumon S.",
                    "initial": "J.S.",
                    "last": "Sattabongkot"
                },
                {
                    "first": "Natavadee",
                    "initial": "N.",
                    "last": "Suwanabun"
                },
                {
                    "first": "Motomi",
                    "initial": "M.",
                    "last": "Torii"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                }
            ],
            "doi": "10.1128/IAI.68.12.6618-6623.2000",
            "firstpage": "6618",
            "issn": "00199567",
            "lastpage": "6623",
            "pmid": "11083773",
            "pub_year": 2000,
            "title": "Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of plasmodium vivax to infect mosquitoes",
            "volume": "68"
        },
        "bib0335": {
            "authors": [
                {
                    "first": "Masanori",
                    "initial": "M.",
                    "last": "Mizutani"
                },
                {
                    "first": "Mitsuhiro",
                    "initial": "M.",
                    "last": "Iyori"
                },
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Blagborough"
                },
                {
                    "first": "Shinya",
                    "initial": "S.",
                    "last": "Fukumoto"
                },
                {
                    "first": "Tomohiro",
                    "initial": "T.",
                    "last": "Funatsu"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                },
                {
                    "first": "Shigeto",
                    "initial": "S.",
                    "last": "Yoshida"
                }
            ],
            "doi": "10.1128/IAI.02040-14",
            "firstpage": "4348",
            "issn": "00199567",
            "lastpage": "4357",
            "pmid": "25092912",
            "pub_year": 2014,
            "title": "Baculovirus-Vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites",
            "volume": "82"
        },
        "bib0340": {
            "authors": [
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Blagborough"
                },
                {
                    "first": "Shigeto",
                    "initial": "S.",
                    "last": "Yoshida"
                },
                {
                    "first": "Jetsumon",
                    "initial": "J.",
                    "last": "Sattabongkot"
                },
                {
                    "first": "Takafumi",
                    "initial": "T.",
                    "last": "Tsuboi"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.06.100",
            "firstpage": "6014",
            "issn": "0264410X",
            "lastpage": "6020",
            "pmid": "20637303",
            "pub_year": 2010,
            "title": "Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission",
            "volume": "28"
        },
        "bib0345": {
            "authors": [
                {
                    "first": "Edward P.",
                    "initial": "E.P.",
                    "last": "Rybicki"
                }
            ],
            "doi": "10.1111/j.1467-7652.2010.00507.x",
            "firstpage": "620",
            "issn": "14677644",
            "lastpage": "637",
            "pmid": "20233333",
            "pub_year": 2010,
            "title": "Plant-made vaccines for humans and animals",
            "volume": "8"
        },
        "bib0350": {
            "authors": [
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Streatfield"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "Kushnir"
                }
            ],
            "doi": "10.4161/hv.7.3.14207",
            "firstpage": "313",
            "issn": "15548600",
            "lastpage": "321",
            "pmid": "21346417",
            "pub_year": 2011,
            "title": "Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond",
            "volume": "7"
        },
        "bib0355": {
            "authors": [
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Stephenson"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "Goran",
                    "initial": "G.",
                    "last": "Orozovic"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Brodelius"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Brodelius"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Horsey"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ugulava"
                },
                {
                    "first": "Abdel Moneim",
                    "initial": "A.M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Shailaja",
                    "initial": "S.",
                    "last": "Rabindran"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Streatfield"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "firstpage": "19",
            "issn": "17502659",
            "lastpage": "25",
            "pmid": "19453476",
            "pub_year": 2007,
            "title": "A launch vector for the production of vaccine antigens in plants.",
            "volume": "1"
        },
        "bib0360": {
            "authors": [
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "de la Rosa"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Horsey"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Stevenson"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ugulava"
                },
                {
                    "first": "Shailaja",
                    "initial": "S.",
                    "last": "Rabindran"
                },
                {
                    "first": "Gene A.",
                    "initial": "G.A.",
                    "last": "Palmer"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.01.068",
            "firstpage": "3111",
            "issn": "0264410X",
            "lastpage": "3114",
            "pmid": "17280756",
            "pub_year": 2007,
            "title": "Immunogenicity of a subunit vaccine against Bacillus anthracis",
            "volume": "25"
        },
        "bib0365": {
            "authors": [
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "Valentina",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Jarred",
                    "initial": "J.",
                    "last": "Lyons"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.01.050",
            "firstpage": "3471",
            "issn": "0264410X",
            "lastpage": "3474",
            "pmid": "19200825",
            "pub_year": 2009,
            "title": "A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague",
            "volume": "27"
        },
        "bib0370": {
            "authors": [
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Horsey"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ugulava"
                },
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Shoji"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "de la Rosa"
                },
                {
                    "first": "Gene A.",
                    "initial": "G.A.",
                    "last": "Palmer"
                },
                {
                    "first": "Shailaja",
                    "initial": "S.",
                    "last": "Rabindran"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Streatfield"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Boyers"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Russell"
                },
                {
                    "first": "Alex",
                    "initial": "A.",
                    "last": "Mann"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Lambkin"
                },
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Oxford"
                },
                {
                    "first": "Geoffrey C.",
                    "initial": "G.C.",
                    "last": "Schild"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1111/j.1750-2659.2008.00037.x",
            "firstpage": "33",
            "issn": "17502640",
            "lastpage": "40",
            "pmid": "19453491",
            "pub_year": 2008,
            "title": "A plant-produced influenza subunit vaccine protects ferrets against virus challenge",
            "volume": "2"
        },
        "bib0375": {
            "authors": [
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Shoji"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "de la Rosa"
                },
                {
                    "first": "Lauren",
                    "initial": "L.",
                    "last": "Goldschmidt"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Horsey"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ugulava"
                },
                {
                    "first": "Gene A.",
                    "initial": "G.A.",
                    "last": "Palmer"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.03.045",
            "firstpage": "2930",
            "issn": "0264410X",
            "lastpage": "2934",
            "pmid": "18440103",
            "pub_year": 2008,
            "title": "Plant-expressed HA as a seasonal influenza vaccine candidate",
            "volume": "26"
        },
        "bib0380": {
            "authors": [
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Shoji"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Rhee"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Horsey"
                },
                {
                    "first": "Gourgopal",
                    "initial": "G.",
                    "last": "Roy"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Green"
                },
                {
                    "first": "Moneim",
                    "initial": "M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Taggart"
                },
                {
                    "first": "Nutan",
                    "initial": "N.",
                    "last": "Mytle"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ugulava"
                },
                {
                    "first": "Shailaja",
                    "initial": "S.",
                    "last": "Rabindran"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.11.108",
            "firstpage": "1087",
            "issn": "0264410X",
            "lastpage": "1092",
            "pmid": "19100806",
            "pub_year": 2009,
            "title": "Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza",
            "volume": "27"
        },
        "bib0385": {
            "authors": [
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Shoji"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Moneim",
                    "initial": "M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Green"
                },
                {
                    "first": "Slobodanka",
                    "initial": "S.",
                    "last": "Manceva"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Rhee"
                },
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ugulava"
                },
                {
                    "first": "Gourgopal",
                    "initial": "G.",
                    "last": "Roy"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.01.051",
            "firstpage": "3467",
            "issn": "0264410X",
            "lastpage": "3470",
            "pmid": "19200814",
            "pub_year": 2009,
            "title": "Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants",
            "volume": "27"
        },
        "bib0390": {
            "authors": [
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Moneim",
                    "initial": "M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Rhee"
                },
                {
                    "first": "Slobodanka D.",
                    "initial": "S.D.",
                    "last": "Manceva"
                },
                {
                    "first": "R. Mark",
                    "initial": "R.M.",
                    "last": "Jones"
                },
                {
                    "first": "Tarlan",
                    "initial": "T.",
                    "last": "Mamedov"
                },
                {
                    "first": "Satish",
                    "initial": "S.",
                    "last": "Sharma"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Streatfield"
                },
                {
                    "first": "Will",
                    "initial": "W.",
                    "last": "Roeffen"
                },
                {
                    "first": "Marga",
                    "initial": "M.",
                    "last": "Van De Vegte-Bolmer"
                },
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Sauerwein"
                },
                {
                    "first": "Yimin",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Muratova"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Miller"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Duffy"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Sinden"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.4161/hv.7.0.14588",
            "firstpage": "191",
            "issn": "15548600",
            "lastpage": "198",
            "pmid": "21266847",
            "pub_year": 2011,
            "title": "Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity",
            "volume": "7"
        },
        "bib0395": {
            "authors": [
                {
                    "first": "R. Mark",
                    "initial": "R.M.",
                    "last": "Jones"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Slobodanka",
                    "initial": "S.",
                    "last": "Manceva"
                },
                {
                    "first": "Sandra K.",
                    "initial": "S.K.",
                    "last": "Gibbs"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Moneim",
                    "initial": "M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Joey",
                    "initial": "J.",
                    "last": "Norikane"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Streatfield"
                },
                {
                    "first": "Marga",
                    "initial": "M.",
                    "last": "Van De Vegte-Bolmer"
                },
                {
                    "first": "Will",
                    "initial": "W.",
                    "last": "Roeffen"
                },
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Sauerwein"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.4161/hv.34366",
            "firstpage": "124",
            "issn": "21645515",
            "lastpage": "132",
            "pmid": "25483525",
            "pub_year": 2015,
            "title": "A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses",
            "volume": "11"
        },
        "bib0400": {
            "authors": [
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Emily K.",
                    "initial": "E.K.",
                    "last": "Forbes"
                },
                {
                    "first": "Anne C.",
                    "initial": "A.C.",
                    "last": "Moore"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1016/j.chom.2008.12.004",
            "firstpage": "95",
            "issn": "19313128",
            "lastpage": "105",
            "pmid": "19154991",
            "pub_year": 2009,
            "title": "Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria",
            "volume": "5"
        },
        "bib0405": {
            "authors": [
                {
                    "first": "Emily K.",
                    "initial": "E.K.",
                    "last": "Forbes"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.4049/jimmunol.1003783",
            "firstpage": "3738",
            "issn": "00221767",
            "lastpage": "3750",
            "pmid": "21876036",
            "pub_year": 2011,
            "title": "Combining liver- and blood-stage malaria viral-vectored vaccines: Investigating mechanisms of CD8 + T cell interference",
            "volume": "187"
        },
        "bib0410": {
            "authors": [
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Edmond J.",
                    "initial": "E.J.",
                    "last": "Remarque"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                },
                {
                    "first": "Anthony A.",
                    "initial": "A.A.",
                    "last": "Holder"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1371/journal.pone.0020977",
            "issn": "19326203",
            "pmid": "21698193",
            "pub_year": 2011,
            "title": "Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of plasmodium falciparum AMA1",
            "volume": "6"
        },
        "bib0415": {
            "authors": [
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Epp"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Moss"
                },
                {
                    "first": "A. A.",
                    "initial": "A.A.",
                    "last": "Holder"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Wilson"
                },
                {
                    "first": "G. P.",
                    "initial": "G.P.",
                    "last": "Gao"
                },
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "E. J.",
                    "initial": "E.J.",
                    "last": "Remarque"
                },
                {
                    "first": "A. W.",
                    "initial": "A.W.",
                    "last": "Thomas"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Ammendola"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "M. D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Seibel"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Van Duivenvoorde"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "A. V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1128/IAI.00315-10",
            "firstpage": "4601",
            "issn": "00199567",
            "lastpage": "4612",
            "pmid": "20713623",
            "pub_year": 2010,
            "title": "New candidate vaccines against blood-stage Plasmodium falciparum malaria: Prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1",
            "volume": "78"
        },
        "bib0420": {
            "authors": [
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Edmond J.",
                    "initial": "E.J.",
                    "last": "Remarque"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Capone"
                },
                {
                    "first": "Mariarosaria",
                    "initial": "M.",
                    "last": "Naddeo"
                },
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Bart W.",
                    "initial": "B.W.",
                    "last": "Faber"
                },
                {
                    "first": "Simone C.",
                    "initial": "S.C.",
                    "last": "De Cassan"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.4049/jimmunol.1001760",
            "firstpage": "7583",
            "issn": "00221767",
            "lastpage": "7595",
            "pmid": "21098232",
            "pub_year": 2010,
            "title": "Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines",
            "volume": "185"
        },
        "bib0425": {
            "authors": [
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Arturo",
                    "initial": "A.",
                    "last": "Reyes-Sandoval"
                },
                {
                    "first": "Geraldine",
                    "initial": "G.",
                    "last": "O'Hara"
                },
                {
                    "first": "Katie",
                    "initial": "K.",
                    "last": "Ewer"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Lawrie"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Goodman"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.4161/hv.6.1.10116",
            "firstpage": "78",
            "issn": "15548600",
            "lastpage": "83",
            "pmid": "20061802",
            "pub_year": 2010,
            "title": "Prime-boost vectored malaria vaccines: Progress and prospects",
            "volume": "6"
        },
        "bib0430": {
            "authors": [
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Sheehy"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Sean C.",
                    "initial": "S.C.",
                    "last": "Elias"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Andrew R.",
                    "initial": "A.R.",
                    "last": "Williams"
                },
                {
                    "first": "Fenella D.",
                    "initial": "F.D.",
                    "last": "Halstead"
                },
                {
                    "first": "Samuel E.",
                    "initial": "S.E.",
                    "last": "Moretz"
                },
                {
                    "first": "Kazutoyo",
                    "initial": "K.",
                    "last": "Miura"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Epp"
                },
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1038/mt.2011.176",
            "firstpage": "2269",
            "issn": "15250016",
            "lastpage": "2276",
            "pub_year": 2011,
            "title": "Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors",
            "volume": "19"
        },
        "bib0435": {
            "authors": [
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Blagborough"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Yimin",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Adrian V.",
                    "initial": "A.V.",
                    "last": "Hill"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1371/journal.pone.0029428",
            "issn": "19326203",
            "pmid": "22216279",
            "pub_year": 2011,
            "title": "A viral vectored prime-boost immunization regime targeting the malaria pfs25 antigen induces transmission-blocking activity",
            "volume": "6"
        },
        "bib0440": {
            "authors": [
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Miyata"
                },
                {
                    "first": "Tetsuya",
                    "initial": "T.",
                    "last": "Harakuni"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Sugawa"
                },
                {
                    "first": "Jetsumon",
                    "initial": "J.",
                    "last": "Sattabongkot"
                },
                {
                    "first": "Aki",
                    "initial": "A.",
                    "last": "Kato"
                },
                {
                    "first": "Mayumi",
                    "initial": "M.",
                    "last": "Tachibana"
                },
                {
                    "first": "Motomi",
                    "initial": "M.",
                    "last": "Torii"
                },
                {
                    "first": "Takafumi",
                    "initial": "T.",
                    "last": "Tsuboi"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Arakawa"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.01.083",
            "firstpage": "2720",
            "issn": "0264410X",
            "lastpage": "2726",
            "pmid": "21315699",
            "pub_year": 2011,
            "title": "Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine",
            "volume": "29"
        },
        "bib0445": {
            "authors": [
                {
                    "first": "Souraya",
                    "initial": "S.",
                    "last": "Ramjanee"
                },
                {
                    "first": "James S.",
                    "initial": "J.S.",
                    "last": "Robertson"
                },
                {
                    "first": "Blandine",
                    "initial": "B.",
                    "last": "Franke-Fayard"
                },
                {
                    "first": "Ria",
                    "initial": "R.",
                    "last": "Sinha"
                },
                {
                    "first": "Andrew P.",
                    "initial": "A.P.",
                    "last": "Waters"
                },
                {
                    "first": "Chris J.",
                    "initial": "C.J.",
                    "last": "Janse"
                },
                {
                    "first": "Yimin",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Blagborough"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Saul"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.09.035",
            "firstpage": "886",
            "issn": "0264410X",
            "lastpage": "894",
            "pmid": "17049690",
            "pub_year": 2007,
            "title": "The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials",
            "volume": "25"
        },
        "bib0450": {
            "authors": [
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                }
            ],
            "doi": "10.1046/j.1462-5822.2002.00229.x",
            "firstpage": "713",
            "issn": "14625814",
            "lastpage": "724",
            "pmid": "12427094",
            "pub_year": 2002,
            "title": "Molecular interactions between Plasmodium and its insect vectors",
            "volume": "4"
        },
        "bib0455": {
            "authors": [
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "Anne C.",
                    "initial": "A.C.",
                    "last": "Moore"
                },
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Anthony A.",
                    "initial": "A.A.",
                    "last": "Holder"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Fergal",
                    "initial": "F.",
                    "last": "Hill"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1038/nm.1850",
            "firstpage": "819",
            "issn": "10788956",
            "lastpage": "821",
            "pmid": "18660818",
            "pub_year": 2008,
            "title": "Effective induction of high-titer antibodies by viral vector vaccines",
            "volume": "14"
        },
        "bib0460": null,
        "bib0465": {
            "authors": [
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Grotendorst"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Carter"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Rosenberg"
                },
                {
                    "first": "L. C.",
                    "initial": "L.C.",
                    "last": "Koontz"
                }
            ],
            "firstpage": "4270",
            "issn": "00221767",
            "lastpage": "4274",
            "pmid": "3517168",
            "pub_year": 1986,
            "title": "Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. I. Resistance of zygotes to the alternative pathway of complement",
            "volume": "136"
        },
        "bib0470": {
            "authors": [
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                },
                {
                    "first": "Ian C.",
                    "initial": "I.C.",
                    "last": "Bathurst"
                },
                {
                    "first": "Philip J.",
                    "initial": "P.J.",
                    "last": "Barr"
                }
            ],
            "doi": "10.1016/0167-7799(92)90280-9",
            "firstpage": "388",
            "issn": "01677799",
            "lastpage": "391",
            "pmid": "1368880",
            "pub_year": 1992,
            "title": "Malaria transmission-blocking vaccines",
            "volume": "10"
        },
        "bib0475": {
            "authors": [
                {
                    "first": "Arno N.",
                    "initial": "A.N.",
                    "last": "Vermeulen"
                },
                {
                    "first": "Thivi",
                    "initial": "T.",
                    "last": "Ponnudurai"
                },
                {
                    "first": "Pieter J.A.",
                    "initial": "P.J.A.",
                    "last": "Beckers"
                },
                {
                    "first": "Jan Peter",
                    "initial": "J.P.",
                    "last": "Verhave"
                },
                {
                    "first": "Mari A.",
                    "initial": "M.A.",
                    "last": "Smits"
                },
                {
                    "first": "Joseph H.E.Th",
                    "initial": "J.H.E.T.",
                    "last": "Meuwissen"
                }
            ],
            "doi": "10.1084/jem.162.5.1460",
            "firstpage": "1460",
            "issn": "00221007",
            "lastpage": "1476",
            "pmid": "2865324",
            "pub_year": 1985,
            "title": "Sequential expression of antigens on sexual stages of plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito",
            "volume": "162"
        },
        "bib0480": {
            "authors": [
                {
                    "first": "G. R.",
                    "initial": "G.R.",
                    "last": "Ranawaka"
                },
                {
                    "first": "S. L.",
                    "initial": "S.L.",
                    "last": "Fleck"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Alejo Blanco"
                },
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                }
            ],
            "doi": "10.1017/S0031182000080653",
            "firstpage": "403",
            "issn": "00311820",
            "lastpage": "411",
            "pmid": "7800408",
            "pub_year": 1994,
            "title": "Characterization of the Modes of Action of Anti-Pbs21 Malaria Transmission-Blocking Immunity: Ookinete to Oocyst Differentiation in Vivo",
            "volume": "109"
        },
        "bib0485": {
            "authors": [
                {
                    "first": "Alexander D.",
                    "initial": "A.D.",
                    "last": "Douglas"
                },
                {
                    "first": "Andrew R.",
                    "initial": "A.R.",
                    "last": "Williams"
                },
                {
                    "first": "Joseph J.",
                    "initial": "J.J.",
                    "last": "Illingworth"
                },
                {
                    "first": "Gathoni",
                    "initial": "G.",
                    "last": "Kamuyu"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "David H.",
                    "initial": "D.H.",
                    "last": "Wyllie"
                },
                {
                    "first": "C\u00e9cile",
                    "initial": "C.",
                    "last": "Crosnier"
                },
                {
                    "first": "Kazutoyo",
                    "initial": "K.",
                    "last": "Miura"
                },
                {
                    "first": "Gavin J.",
                    "initial": "G.J.",
                    "last": "Wright"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Faith H.",
                    "initial": "F.H.",
                    "last": "Osier"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Marsh"
                },
                {
                    "first": "Alison V.",
                    "initial": "A.V.",
                    "last": "Turner"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1038/ncomms1615",
            "issn": "20411723",
            "pmid": "22186897",
            "pub_year": 2011,
            "title": "The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody",
            "volume": "2"
        },
        "bib0490": {
            "authors": [
                {
                    "first": "M. C.",
                    "initial": "M.C.",
                    "last": "Kapulu"
                },
                {
                    "first": "D. F.",
                    "initial": "D.F.",
                    "last": "Da"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Miura"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "A. M.",
                    "initial": "A.M.",
                    "last": "Blagborough"
                },
                {
                    "first": "T. S.",
                    "initial": "T.S.",
                    "last": "Churcher"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Nikolaeva"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Williams"
                },
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Sangare"
                },
                {
                    "first": "A. V.",
                    "initial": "A.V.",
                    "last": "Turner"
                },
                {
                    "first": "M. G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "U.",
                    "initial": "U.",
                    "last": "Straschil"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Tsuboi"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "A. V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Cohuet"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Biswas"
                }
            ],
            "doi": "10.1038/srep11193",
            "issn": "20452322",
            "pmid": "26063320",
            "pub_year": 2015,
            "title": "Comparative assessment of transmission-blocking vaccine candidates against plasmodium falciparum",
            "volume": "5"
        }
    },
    "body_text": [
        {
            "endOffset": 77503,
            "parents": [],
            "refoffsets": {
                "bib0335": {
                    "endOffset": 77502,
                    "startOffset": 77495
                },
                "bib0445": {
                    "endOffset": 77502,
                    "startOffset": 77495
                }
            },
            "secId": "sec0095",
            "sentence": "When examining the ability of serum to recognize native Pvs25 by IFA, sera from all regimes resulted in surface staining, corresponding to surface localization of Pvs25 [18,40].",
            "startOffset": 77326,
            "title": "Discussion"
        },
        {
            "endOffset": 65849,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Plates were developed using pNPP and read at OD405 until end-point detection set for each antigen.",
            "startOffset": 65751,
            "title": "ELISA"
        },
        {
            "endOffset": 80481,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Obviously, further dose ranging studies examining proportional immunizations will need to be conducted before perusing product development in human subjects.",
            "startOffset": 80324,
            "title": "Discussion"
        },
        {
            "endOffset": 81452,
            "parents": [],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 81248,
                    "startOffset": 81244
                }
            },
            "secId": "sec0095",
            "sentence": "Crucially, the Baculovirus-Dual-Expression system (BDES) described in Blagborough et al. [19] is not currently approved for use in human trials, whereas both adenoviral and Nicotiana-based expression systems have an extensive track record for the production of antigens to be used in human trials.",
            "startOffset": 81155,
            "title": "Discussion"
        },
        {
            "endOffset": 65534,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Sera from mice were collected by tail-bleed prior to boost and challenge.",
            "startOffset": 65461,
            "title": "ELISA"
        },
        {
            "endOffset": 67059,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Serum was mixed with P. vivax-infected blood cells (1:1 v/v ratio).",
            "startOffset": 66992,
            "title": "DMFA"
        },
        {
            "endOffset": 67739,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "All procedures were performed in accordance with the UK Animals (Scientific Procedures) Act (PPL 70/7185) and approved by the Imperial College AWERB.",
            "startOffset": 67590,
            "title": "Ethical statement"
        },
        {
            "endOffset": 65115,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Viral-vectored vaccines were prepared in sterile, endotoxin-free PBS prior to immunization, with doses of 1 \u00d7 1010 viral particles of ChAd63 vaccines at week 0 and 1 \u00d7 107 plaque forming units of MVA vaccines at week 8.",
            "startOffset": 64896,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 63601,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Plasmids were transfected into 2 \u00d7 106 cells/mL HEK293E cells.",
            "startOffset": 63539,
            "title": "Production of recombinant Pvs25 (r-Pvs25) protein"
        },
        {
            "endOffset": 63179,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Antigen sequence (excluding the glycosylphosphatidylinositol (GPI) anchor addition site), i.e. Ala23-Leu195 of Pvs25 (Sal I strain), was obtained from the NCBI protein database, codon optimized for expression in Homo sapiens (GeneArt\u00ae, Life Technologies, Germany), and the predicted native signal peptide replaced with the human tissue plasminogen activator signal peptide.",
            "startOffset": 62806,
            "title": "Production of viral vector-based Pvs25 vaccines"
        },
        {
            "endOffset": 58060,
            "parents": [],
            "refoffsets": {
                "bib0345": {
                    "endOffset": 58059,
                    "startOffset": 58052
                },
                "bib0350": {
                    "endOffset": 58059,
                    "startOffset": 58052
                }
            },
            "secId": "sec0005",
            "sentence": "Previously, studies have examined the potential of utilizing plants as a cost-effective and scalable platform for vaccine production [20,21].",
            "startOffset": 57919,
            "title": "Introduction"
        },
        {
            "endOffset": 69852,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "To examine immunogenicity, pre-boost and end-point sera were analyzed by ELISA against recombinant Pvs25-FhCMB (comprising LicKM) following immunization as outlined in Fig. 2.",
            "startOffset": 69677,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 72071,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0445": {
                    "endOffset": 72027,
                    "startOffset": 72023
                }
            },
            "secId": "sec0085",
            "sentence": "For examination of transmission blockade in vivo, five immunized mice per challenge group were infected with Pvs25DR3 [40], and five mice infected with WT P. berghei.",
            "startOffset": 71905,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 64032,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Eighty mice (Female BALB/c, 6\u20138 weeks of age (Harlan, UK)) were divided into groups of 10 mice, each group used for an individual immunization regime (Fig. 2).",
            "startOffset": 63873,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 76298,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The highest mean titer was observed with regime 1 (prime/boost with Pvs25-FhCMB/Abisco-100), whereas the lowest anti-Pvs25-FhCMB end-point titers were elicited by regime 3 (Pvs25-ChAd63/MVA).",
            "startOffset": 76107,
            "title": "Discussion"
        },
        {
            "endOffset": 59943,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The ability of antiserum generated from each immunization regime to recognize native Pvs25 was examined by immunofluorescence assay (IFA).",
            "startOffset": 59805,
            "title": "Introduction"
        },
        {
            "endOffset": 82251,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The ability of the plant-derived antigens tested in this study to induce in vivo and ex vivo efficacy similar to previously examined P25-based immunogens lends weight to their continued development within the TBV pipeline.",
            "startOffset": 82029,
            "title": "Discussion"
        },
        {
            "endOffset": 60481,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Efficacy was examined by direct feeding assay (DFA), and in direct membrane feeding assay (DMFA) against P. vivax field samples.",
            "startOffset": 60353,
            "title": "Introduction"
        },
        {
            "endOffset": 71139,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "To assess end-point response to Pvs25 per se, as opposed to Pvs25-LicKM conjugate, ELISA was carried out against recombinant r-Pvs25 (Fig. 3b).",
            "startOffset": 70996,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 59402,
            "parents": [],
            "refoffsets": {
                "bib0400": {
                    "endOffset": 59359,
                    "startOffset": 59352
                },
                "bib0405": {
                    "endOffset": 59359,
                    "startOffset": 59352
                },
                "bib0410": {
                    "endOffset": 59376,
                    "startOffset": 59369
                },
                "bib0415": {
                    "endOffset": 59376,
                    "startOffset": 59369
                },
                "bib0420": {
                    "endOffset": 59401,
                    "startOffset": 59397
                }
            },
            "secId": "sec0005",
            "sentence": "Recently, the development of viral vectored blood-stage malaria vaccines has shown that high-level antibody responses can be induced by the adenovirus in mice [31,32], rabbits [33,34] and rhesus macaques [35].",
            "startOffset": 59193,
            "title": "Introduction"
        },
        {
            "endOffset": 74982,
            "parents": [],
            "secId": "sec0095",
            "sentence": "These results indicated the utility of plant-derived Pfs25 as a TBV, and the importance of appropriate carrier molecules to enhance immunogenicity.",
            "startOffset": 74835,
            "title": "Discussion"
        },
        {
            "endOffset": 57674,
            "parents": [],
            "refoffsets": {
                "bib0310": {
                    "endOffset": 57589,
                    "startOffset": 57585
                }
            },
            "secId": "sec0005",
            "sentence": "P25 is characterized by the presence of epidermal growth factor (EGF)-like motifs, multiple cysteine residues and a complex tertiary structure [13], making it challenging to produce recombinant protein with appropriate conformation.",
            "startOffset": 57442,
            "title": "Introduction"
        },
        {
            "endOffset": 57919,
            "parents": [],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 57866,
                    "startOffset": 57859
                },
                "bib0325": {
                    "endOffset": 57866,
                    "startOffset": 57859
                },
                "bib0330": {
                    "endOffset": 57866,
                    "startOffset": 57859
                },
                "bib0335": {
                    "endOffset": 57918,
                    "startOffset": 57908
                },
                "bib0340": {
                    "endOffset": 57918,
                    "startOffset": 57908
                },
                "bib0440": {
                    "endOffset": 57918,
                    "startOffset": 57908
                }
            },
            "secId": "sec0005",
            "sentence": "Previous studies that have successfully expressed P. vivax P25 (Pvs25) in native conformation have been limited to small-scale studies, with \u201cclassical\u201d recombinant expression systems [15\u201317] or using multiple viral delivery systems [18,19,39].",
            "startOffset": 57675,
            "title": "Introduction"
        },
        {
            "endOffset": 60848,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Our data indicate that Nicotiana-produced Pvs25 antigen can induce significant TB responses in vivo and ex vivo, and that this technology could be used as part of a successful TBV immunization regime, either alone, or in combination with other delivery systems.",
            "startOffset": 60587,
            "title": "Introduction"
        },
        {
            "endOffset": 60586,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Maximal efficacy was observed when combining adenoviral and plant-derived immunogens in a single regime.",
            "startOffset": 60482,
            "title": "Introduction"
        },
        {
            "endOffset": 73153,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0335": {
                    "endOffset": 73058,
                    "startOffset": 73048
                },
                "bib0340": {
                    "endOffset": 73058,
                    "startOffset": 73048
                },
                "bib0445": {
                    "endOffset": 73058,
                    "startOffset": 73048
                }
            },
            "secId": "sec0085",
            "sentence": "As previously demonstrated [18,19,40], challenge with WT P. berghei gives rise to higher oocyst numbers than observed with Pvs25DR3.",
            "startOffset": 73021,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 74406,
            "parents": [],
            "refoffsets": {
                "bib0460": {
                    "endOffset": 74405,
                    "startOffset": 74398
                },
                "bib0465": {
                    "endOffset": 74405,
                    "startOffset": 74398
                },
                "bib0470": {
                    "endOffset": 74405,
                    "startOffset": 74398
                },
                "bib0475": {
                    "endOffset": 74405,
                    "startOffset": 74398
                },
                "bib0480": {
                    "endOffset": 74405,
                    "startOffset": 74398
                }
            },
            "secId": "sec0095",
            "sentence": "Anti-malarial TB immunity can be mediated by antibodies that inhibit parasite development in the mosquito midgut [43\u201347].",
            "startOffset": 74285,
            "title": "Discussion"
        },
        {
            "endOffset": 62020,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Plants were homogenized, extracted with Triton X-100 (0.5%), centrifuged (16,000 \u00d7 g, 15 min, 4 \u00b0C) and filtrated (Sartopore 2, 0.45/0.2 \u03bcm) prior to loading onto IMAC resin (Ni-Sepharose Fast-Flow, GE Healthcare).",
            "startOffset": 61806,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 57130,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Briefly, antibodies produced within an individual in response to vaccination are ingested by the mosquito along with gametocytes, during a bloodmeal.",
            "startOffset": 56981,
            "title": "Introduction"
        },
        {
            "endOffset": 68489,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0065",
            "sentence": "P-values < 0.05 were considered statistically significant.",
            "startOffset": 68431,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 73284,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "There was no detectable TB effect following WT P. berghei infection, indicating specific anti-Pvs25-derived transmission blockade.",
            "startOffset": 73154,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 55834,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Of the five species of malaria parasites that infect humans, Plasmodium falciparum and Plasmodium vivax lead to the greatest burden of disease.",
            "startOffset": 55691,
            "title": "Introduction"
        },
        {
            "endOffset": 66991,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Ninety microliter of pooled serum from mice immunized with ChAd63u-Pvs25/Pvs25-FhCMB boost (regime 4) or mice immunized with ChAd63-GFP/LicKM boost (regime 8) were mixed with 90 \u03bcL of heat-inactivated AB serum from naive donors.",
            "startOffset": 66763,
            "title": "DMFA"
        },
        {
            "endOffset": 69100,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Pvs25-FhCMB was recovered to >90% purity of TP using a two-column chromatography approach consisting of IMAC followed by anion exchange chromatography (Capto Q).",
            "startOffset": 68939,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 67917,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "The Office of Laboratory Animal Welfare Assurance for Imperial College covers all Public Health Service supported activities involving live vertebrates in the US (no. A5634-01).",
            "startOffset": 67740,
            "title": "Ethical statement"
        },
        {
            "endOffset": 58447,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In related studies, this system has produced soluble versions of P. falciparum P25 (Pfs25), either as stand-alone proteins or as fusions to the modified lichenase carrier molecule (LicKM).",
            "startOffset": 58259,
            "title": "Introduction"
        },
        {
            "endOffset": 78081,
            "parents": [],
            "refoffsets": {
                "bib0335": {
                    "endOffset": 77907,
                    "startOffset": 77897
                },
                "bib0340": {
                    "endOffset": 77907,
                    "startOffset": 77897
                },
                "bib0445": {
                    "endOffset": 77907,
                    "startOffset": 77897
                }
            },
            "secId": "sec0095",
            "sentence": "These experiments employed a proven transgenic model [18,19,40] to compare the ability of immunization to reduce oocyst development in the mosquito, giving in vivo data to examine the comparative potency of potential Pvs25-targeted TBVs.",
            "startOffset": 77844,
            "title": "Discussion"
        },
        {
            "endOffset": 73979,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0090",
            "sentence": "Reduction in both intensity and prevalence were significant compared to control feeds (p = 0.0001 and p = 0.0033, respectively).",
            "startOffset": 73851,
            "title": "Evaluation of ex vivo TB activity (DMFA)"
        },
        {
            "endOffset": 77095,
            "parents": [],
            "secId": "sec0095",
            "sentence": "It should be stated that no detectable correlation between anti-Pvs25 titer and transmission-blocking efficacy in individual mice was observed, supporting the hypothesis that antibody titer is not necessarily the key parameter for predicting TBV efficacy.",
            "startOffset": 76840,
            "title": "Discussion"
        },
        {
            "endOffset": 77843,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Although high titers are desirable, the functional effect of immunization on intensity and prevalence remains the key readout to measure TBV effectiveness.",
            "startOffset": 77688,
            "title": "Discussion"
        },
        {
            "endOffset": 78349,
            "parents": [],
            "secId": "sec0095",
            "sentence": "In this study, immunization with the Pvs25-ChAd63/MVA platform (regime 3) led to the lowest observed TB effect (30.0% reduction in intensity/35.6% reduction in prevalence).",
            "startOffset": 78177,
            "title": "Discussion"
        },
        {
            "endOffset": 62335,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "SDS-PAGE was performed on a 10% acrylamide gel and Coomassie stained.",
            "startOffset": 62266,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 65934,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "For r-Pvs25 ELISA, control regime titres were subtracted from mean end-point titres.",
            "startOffset": 65850,
            "title": "ELISA"
        },
        {
            "endOffset": 70543,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "The highest mean titer was observed in regime 1 (Pvs25-FhCMB + Abisco-100).",
            "startOffset": 70468,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 58677,
            "parents": [],
            "refoffsets": {
                "bib0390": {
                    "endOffset": 58676,
                    "startOffset": 58669
                },
                "bib0395": {
                    "endOffset": 58676,
                    "startOffset": 58669
                }
            },
            "secId": "sec0005",
            "sentence": "These antibodies demonstrated potent TB activity [29,30].",
            "startOffset": 58620,
            "title": "Introduction"
        },
        {
            "endOffset": 70995,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "End-point titers resulting from immunization with Pvs25-ChAd63/MVA (regime 3) were significantly lower than those detected in all other groups (compared to regime 1: p < 0.0001; compared to 2 (p = 0.0163); compared to 4 (p = 0.0003).",
            "startOffset": 70762,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 61379,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0355": {
                    "endOffset": 61140,
                    "startOffset": 61136
                }
            },
            "secId": "sec0015",
            "sentence": "The sequence was fused to the C-terminus of LicKM (NCBI accession number ABG78599) [22], containing pathogen-related-protein 1a signal peptide (PR-1a) [(NCBI accession BAA14220)] at the N-terminus, the hexa-histidine (6xHis) tag and the endoplasmic reticulum retention signal at the C-terminus, to yield Pvs25\u2013FhCMB (Fig. 1a).",
            "startOffset": 61053,
            "title": "Pvs25-FhCMB cloning and expression"
        },
        {
            "endOffset": 62089,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Proteins was eluted and loaded onto a CaptoQ column (GE Healthcare).",
            "startOffset": 62021,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 80229,
            "parents": [],
            "refoffsets": {
                "bib0440": {
                    "endOffset": 80054,
                    "startOffset": 80050
                }
            },
            "secId": "sec0095",
            "sentence": "These results are broadly comparable to results observed using serum generated from i.m. delivery of adenoviral-vectored Pvs25 in mice, described in Miyata et al. [39], where DMFA (carried out in identical conditions to those described here) resulted in reported reductions in oocyst intensity and prevalence of 84.1% and 41.7%, respectively.",
            "startOffset": 79887,
            "title": "Discussion"
        },
        {
            "endOffset": 68379,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0065",
            "sentence": "For DFA and DMFA, significance was assessed using Mann\u2013Whitney U (to examine differences in intensity) and Fisher's exact probability (to examine differences in prevalence).",
            "startOffset": 68206,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 56210,
            "parents": [],
            "refoffsets": {
                "bib0250": {
                    "endOffset": 56209,
                    "startOffset": 56204
                },
                "bib0260": {
                    "endOffset": 56209,
                    "startOffset": 56204
                }
            },
            "secId": "sec0005",
            "sentence": "P. vivax is the most widely distributed human malaria parasite, with 2.5 billion people at risk of infection, and 80\u2212300 million cases per annum [1,3].",
            "startOffset": 56059,
            "title": "Introduction"
        },
        {
            "endOffset": 75500,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Pvs25-FhCMB with Alhydrogel; 3).",
            "startOffset": 75468,
            "title": "Discussion"
        },
        {
            "endOffset": 66677,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Twelve days later, midguts were dissected, and oocyst prevalence and intensity recorded and inhibition, these values were compared to intensity and prevalence in mice immunized with appropriate controls.",
            "startOffset": 66474,
            "title": "Parasite maintenance and challenge/DFA"
        },
        {
            "endOffset": 65358,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "For regimens where Pvs25-FhCMB protein was used for immunization and boost, sera were collected at days 0, 21 and 42.",
            "startOffset": 65241,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 71717,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Specific-specific staining was observed using sera from immunization regimes 1, 2, 3 and 4 (Fig. 3c), confirming the ability of generated serum to recognize native Pvs25.",
            "startOffset": 71547,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 58258,
            "parents": [],
            "refoffsets": {
                "bib0355": {
                    "endOffset": 58173,
                    "startOffset": 58169
                },
                "bib0360": {
                    "endOffset": 58257,
                    "startOffset": 58250
                },
                "bib0365": {
                    "endOffset": 58257,
                    "startOffset": 58250
                },
                "bib0370": {
                    "endOffset": 58257,
                    "startOffset": 58250
                },
                "bib0375": {
                    "endOffset": 58257,
                    "startOffset": 58250
                },
                "bib0380": {
                    "endOffset": 58257,
                    "startOffset": 58250
                },
                "bib0385": {
                    "endOffset": 58257,
                    "startOffset": 58250
                }
            },
            "secId": "sec0005",
            "sentence": "Nicotiana benthamiana has been used in conjunction with a hybrid plant virus vector-based expression system [22] to produce subunit vaccine candidates against influenza, plague and anthrax [23\u201328].",
            "startOffset": 58061,
            "title": "Introduction"
        },
        {
            "endOffset": 74834,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The resulting protein induced high titers with long-lasting TB activity in mice.",
            "startOffset": 74754,
            "title": "Discussion"
        },
        {
            "endOffset": 56881,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The importance of vaccines against P. vivax is well understood, but a lack of long-term in vitro culture systems and suitable animal models have hindered developmental advances.",
            "startOffset": 56704,
            "title": "Introduction"
        },
        {
            "endOffset": 64364,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Transmission blockade observed with 2.34 was considered non-specific and not attributed to Pvs25 immunization.",
            "startOffset": 64254,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 71863,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Staining was not observed with sera from any regime against WT ookinetes, or with sera derived from control regimes (i.e. regimes 5, 6, 7 and 8).",
            "startOffset": 71718,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 66473,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 66401,
                    "startOffset": 66397
                }
            },
            "secId": "sec0045",
            "sentence": "Three days post-infection, DFA was performed as described in Blagborough et al. [19], with >50 Anopheles stephensi mosquitoes allowed to feed on each mouse.",
            "startOffset": 66317,
            "title": "Parasite maintenance and challenge/DFA"
        },
        {
            "endOffset": 66181,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0445": {
                    "endOffset": 66180,
                    "startOffset": 66173
                },
                "bib0450": {
                    "endOffset": 66180,
                    "startOffset": 66173
                }
            },
            "secId": "sec0045",
            "sentence": "Routine maintenance of P. berghei was carried out as described previously [40,41].",
            "startOffset": 66099,
            "title": "Parasite maintenance and challenge/DFA"
        },
        {
            "endOffset": 70467,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "There was a significant increase in titers following booster immunizations in regimes 1, 2 and 4 (p < 0.05), with the most pronounced increase detected in regime 4, and a non-significant increase in titers following boost in regime 3 (p = 0.145).",
            "startOffset": 70221,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 79105,
            "parents": [],
            "secId": "sec0095",
            "sentence": "In the absence of adenoviral delivery, a potent response is still induced by regime 1, prime/boost with Pvs25-FhCMB/Abisco-100, generating the second highest titers and TB responses (65.25% reduction in intensity/54.1% reduction in prevalence).",
            "startOffset": 78861,
            "title": "Discussion"
        },
        {
            "endOffset": 73717,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0090",
            "sentence": "Results showed that the intensity and prevalence of oocyst infection on the mosquito midgut was profoundly reduced in comparison with serum collected from the control group immunized with GFP-ChAd63 and boosted with LicKM/Abisco-100 (regime 8) (Fig. 4).",
            "startOffset": 73464,
            "title": "Evaluation of ex vivo TB activity (DMFA)"
        },
        {
            "endOffset": 65240,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0455": {
                    "endOffset": 65239,
                    "startOffset": 65235
                }
            },
            "secId": "sec0035",
            "sentence": "Control mice were immunized with ChAd63 and MVA expressing GFP as an irrelevant antigen in place of Pvs25 (Ad-MVA GFP) [42].",
            "startOffset": 65116,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 78860,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The TB responses generated following this regime are the highest induced within this comparative study, clearly demonstrating the attractiveness of combining adenoviral delivery with a protein antigen.",
            "startOffset": 78659,
            "title": "Discussion"
        },
        {
            "endOffset": 80323,
            "parents": [],
            "secId": "sec0095",
            "sentence": "These promising results were achieved with an immunization of 50 \u03bcg of Pvs25-FhCMB per mouse.",
            "startOffset": 80230,
            "title": "Discussion"
        },
        {
            "endOffset": 79886,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The TB potential of regime 4 (Pvs25-ChAd63/Pvs25-FhCMB \u2013 the highest performing regime in the DFA), was further evaluated by DMFA, resulting in a mean 85.3%/25.5% reduction in intensity and prevalence respectively, confirming the ability of antibodies generated by this regime to block transmission in field relevant assays.",
            "startOffset": 79562,
            "title": "Discussion"
        },
        {
            "endOffset": 81716,
            "parents": [],
            "secId": "sec0095",
            "sentence": "TB efficacy was assessed using a homologous chimeric parasite (Pfs25DR3) generated identically to Pvs25DR3.",
            "startOffset": 81609,
            "title": "Discussion"
        },
        {
            "endOffset": 68854,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Solubility was examined using an anti-4xHis mAb by Western blot of total unclarified protein homogenate (H), total soluble protein (S) and total soluble protein extracted with 0.5% Triton X-100 (dS) (Fig. 1b).",
            "startOffset": 68645,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 56058,
            "parents": [],
            "refoffsets": {
                "bib0255": {
                    "endOffset": 56057,
                    "startOffset": 56052
                },
                "bib0260": {
                    "endOffset": 56057,
                    "startOffset": 56052
                },
                "bib0265": {
                    "endOffset": 56057,
                    "startOffset": 56052
                }
            },
            "secId": "sec0005",
            "sentence": "While P. falciparum is responsible for the majority of malaria-linked deaths, P. vivax can cause relapses months after the first infection [4] caused by hypnozoites, and require specialized treatment, e.g. primaquine [2\u20134].",
            "startOffset": 55835,
            "title": "Introduction"
        },
        {
            "endOffset": 71546,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "To confirm the induction of Pvs25-specific antibodies that recognize native protein, we performed IFA on P. berghei Pvs25DR3 ookinetes using pooled end-point serum.",
            "startOffset": 71382,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 72473,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "For each Pvs25-derived regime, a TB effect was observed following infection with P. berghei Pvs25DR3.",
            "startOffset": 72372,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 57441,
            "parents": [],
            "refoffsets": {
                "bib0305": {
                    "endOffset": 57440,
                    "startOffset": 57436
                }
            },
            "secId": "sec0005",
            "sentence": "One of the primary targets for TBV development is the P25 protein, expressed predominantly on the surface of the Plasmodium zygote and ookinete [12].",
            "startOffset": 57292,
            "title": "Introduction"
        },
        {
            "endOffset": 75866,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Ability of each regime to produce antibody capable of recognizing native protein and exhibit TB efficacy (in vivo and ex vivo, with field samples) was examined.",
            "startOffset": 75706,
            "title": "Discussion"
        },
        {
            "endOffset": 56980,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Malaria transmission-blocking (TB) vaccines (TBVs) show promise as a method to reduce transmission.",
            "startOffset": 56881,
            "title": "Introduction"
        },
        {
            "endOffset": 68644,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Pvs25-FhCMB expression was evaluated by Western blot of clarified extract (Fig. 1b).",
            "startOffset": 68560,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 56467,
            "parents": [],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 56291,
                    "startOffset": 56288
                },
                "bib0275": {
                    "endOffset": 56389,
                    "startOffset": 56384
                },
                "bib0280": {
                    "endOffset": 56389,
                    "startOffset": 56384
                }
            },
            "secId": "sec0005",
            "sentence": "Multiple factors, including the appearance of chloroquine-resistant P. vivax [5], lack of practical alternatives to primaquine, combined with increasing global temperatures [6,7], have raised concerns related to increased risks of P. vivax-induced disease.",
            "startOffset": 56211,
            "title": "Introduction"
        },
        {
            "endOffset": 74284,
            "parents": [],
            "secId": "sec0095",
            "sentence": "TBVs are one potential component of this approach.",
            "startOffset": 74234,
            "title": "Discussion"
        },
        {
            "endOffset": 59192,
            "parents": [],
            "secId": "sec0005",
            "sentence": "We examined efficacy of this candidate vaccine by performing a head-to-head comparison of induced TB potency following mouse immunization with recombinant Pvs25-FhCMB in the presence of two clinically relevant adjuvants: Alhydrogel, a common aluminium hydroxide wet gel suspension, and Abisco-100, a non-toxic saponin-based adjuvant, and compared these to immunization with a lead adenoviral vaccine platform.",
            "startOffset": 58783,
            "title": "Introduction"
        },
        {
            "endOffset": 69295,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "When Pfs25-FhCMB was run in non-reducing buffer, a single band, migrating at a similar molecular weight is observed.",
            "startOffset": 69179,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 68125,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Protocol for blood collection from Thai patients (protocol # TMEC-11-033) was approved by Ethical Committees from the Faculty of Tropical Medicine, Mahidol University and Ministry of Public Health, Thailand.",
            "startOffset": 67918,
            "title": "Ethical statement"
        },
        {
            "endOffset": 76106,
            "parents": [],
            "secId": "sec0095",
            "sentence": "As expected, a booster dose significantly increased the antibody titer against Pvs25-FhCMB in each regime.",
            "startOffset": 76000,
            "title": "Discussion"
        },
        {
            "endOffset": 65656,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Nunc-Immuno Maxisorp 96-well plates (NUNC) were coated with 100 ng recombinant protein (Pvs25FhCMB or r-Pvs25) overnight.",
            "startOffset": 65535,
            "title": "ELISA"
        },
        {
            "endOffset": 70761,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Differences detected between mean end-point titers from regimes 1, 2 and 4 were not statistically significant (p > 0.05).",
            "startOffset": 70640,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 81154,
            "parents": [],
            "secId": "sec0095",
            "sentence": "These results are comparable to the 74.5% (intensity)/68.3% (prevalence) reduction seen using regime 4 (Pvs25-ChAd63/Pvs25-FhCMB boost), but are higher than the efficacy observed with other immunogens and adjuvants used within this study.",
            "startOffset": 80916,
            "title": "Discussion"
        },
        {
            "endOffset": 55581,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Malaria is a global disease caused by parasites of the genus Plasmodium.",
            "startOffset": 55509,
            "title": "Introduction"
        },
        {
            "endOffset": 64253,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0445": {
                    "endOffset": 64188,
                    "startOffset": 64184
                }
            },
            "secId": "sec0035",
            "sentence": "In each group, five mice were challenged with Pvs25DR3 [40], and five were challenged with wild-type (WT) P. berghei (2.34).",
            "startOffset": 64129,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 75999,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Immunization resulted in immunogen-specific responses against recombinant Pvs25-FhCMB and r-Pvs25 in all immunization regimes tested.",
            "startOffset": 75866,
            "title": "Discussion"
        },
        {
            "endOffset": 72371,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Transmission blockade was assessed as reduction in intensity and prevalence with respect to the relevant non-Pvs25 control regimes (i.e. regime 1 is controlled by regime 5, regime 2 by regime 6, regime 3 by regime 7 and regime 4 by regime 8\u2013Table 1b).",
            "startOffset": 72120,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 61458,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0355": {
                    "endOffset": 61457,
                    "startOffset": 61450
                },
                "bib0380": {
                    "endOffset": 61457,
                    "startOffset": 61450
                }
            },
            "secId": "sec0015",
            "sentence": "The gene was cloned into the TMV-based hybrid expression vector pGRD4 [22,27].",
            "startOffset": 61380,
            "title": "Pvs25-FhCMB cloning and expression"
        },
        {
            "endOffset": 66058,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "The cut-off for determining end-point titer was the mean OD value for pre-immune sera + three times the standard deviation.",
            "startOffset": 65935,
            "title": "ELISA"
        },
        {
            "endOffset": 66762,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Peripheral blood was collected from P. vivax infected Thai volunteer patients.",
            "startOffset": 66684,
            "title": "DMFA"
        },
        {
            "endOffset": 60352,
            "parents": [],
            "secId": "sec0005",
            "sentence": "We additionally examined the benefit of a heterologous prime/boost regimen by priming animals with Pvs25-FhCMB followed by boosting with recombinant chimpanzee adenovirus expressing Pvs25 (ChAd63-Pvs25).",
            "startOffset": 60149,
            "title": "Introduction"
        },
        {
            "endOffset": 60148,
            "parents": [],
            "refoffsets": {
                "bib0335": {
                    "endOffset": 60147,
                    "startOffset": 60137
                },
                "bib0340": {
                    "endOffset": 60147,
                    "startOffset": 60137
                },
                "bib0445": {
                    "endOffset": 60147,
                    "startOffset": 60137
                }
            },
            "secId": "sec0005",
            "sentence": "TB activity was assessed in vivo, using a transgenic rodent malaria parasite P. berghei (Pvs25DR3) expressing Pvs25, enabling rapid, safe and cost-effective examination of anti-Pvs25 responses [18,19,40].",
            "startOffset": 59944,
            "title": "Introduction"
        },
        {
            "endOffset": 64129,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Regimes 1\u22124 were experimental whereas regimes 5\u22128 were immunized (i.m.) with control immunogens.",
            "startOffset": 64033,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 73020,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Direct correlation between anti-Pvs25 titer and transmission-blocking efficacy in individual mice was not observed with any significance.",
            "startOffset": 72883,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 75139,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Here, in a parallel study, we describe the production and purification of soluble, Pvs25 recombinant antigen (Pvs25-FhCMB), using a viral plant-based system.",
            "startOffset": 74982,
            "title": "Discussion"
        },
        {
            "endOffset": 75607,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Viral delivery of Pvs25 (Pvs25-ChAd63) with an MVA boost (i.e. classical Adeno-MVA \u2018prime-boost\u2019); and 4).",
            "startOffset": 75501,
            "title": "Discussion"
        },
        {
            "endOffset": 57291,
            "parents": [],
            "refoffsets": {
                "bib0295": {
                    "endOffset": 57290,
                    "startOffset": 57283
                },
                "bib0300": {
                    "endOffset": 57290,
                    "startOffset": 57283
                }
            },
            "secId": "sec0005",
            "sentence": "These antibodies prevent parasite development in the mosquito midgut by binding to surface proteins of the sexual stages, impeding further transmission [10,11].",
            "startOffset": 57131,
            "title": "Introduction"
        },
        {
            "endOffset": 63850,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Soluble recombinant protein (r-Pvs25) was affinity-purified using a HiTrap HP nickel column (GE Healthcare, USA), followed by size exclusion chromatography using a Superdex 200 pg gel filtration column (GE Healthcare, UK) and confirmed by SDS-PAGE.",
            "startOffset": 63602,
            "title": "Production of recombinant Pvs25 (r-Pvs25) protein"
        },
        {
            "endOffset": 76692,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Under these conditions, the highest titer was observed with regime 4 (Pvs25-ChAd63/Pvs25-FhCMB/Abisco-100), and the lowest with regime 2 (Pvs25-FhCMB/Alhydrogel).",
            "startOffset": 76530,
            "title": "Discussion"
        },
        {
            "endOffset": 77688,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Staining was not observed with sera collected from mice immunized with control regimes (regimes 5, 6, 7 and 8), or when IFAs were conducted on non-Pvs25-expressing (WT 2.34) ookinetes.",
            "startOffset": 77504,
            "title": "Discussion"
        },
        {
            "endOffset": 69486,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Analysis by analytical SEC indicates a single prominent peak eluting at a size equivalent to a 45 kDa standard (Fig. 1d), in good agreement with the theoretical molecular weight of 46.4 kDa.",
            "startOffset": 69296,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 74057,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Future control of malaria will require a multidimensional approach.",
            "startOffset": 73990,
            "title": "Discussion"
        },
        {
            "endOffset": 75425,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Induction of functional TB antibody responses against Pvs25 was assessed, following immunization with four different regimes: 1).",
            "startOffset": 75296,
            "title": "Discussion"
        },
        {
            "endOffset": 66316,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 66315,
                    "startOffset": 66308
                },
                "bib0445": {
                    "endOffset": 66315,
                    "startOffset": 66308
                }
            },
            "secId": "sec0045",
            "sentence": "Prior to challenge, mice were PHz treated, and 3 days later infected i.p. with 106 P. berghei ANKA 2.34 or P. berghei Pvs25DR3 [19,40].",
            "startOffset": 66181,
            "title": "Parasite maintenance and challenge/DFA"
        },
        {
            "endOffset": 55690,
            "parents": [],
            "refoffsets": {
                "bib0250": {
                    "endOffset": 55689,
                    "startOffset": 55684
                },
                "bib0255": {
                    "endOffset": 55689,
                    "startOffset": 55684
                }
            },
            "secId": "sec0005",
            "sentence": "An estimated 207 million cases of malaria are reported annually, causing approximately 627,000 deaths [1,2].",
            "startOffset": 55582,
            "title": "Introduction"
        },
        {
            "endOffset": 65750,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Test sera was incubated for 2 h followed by goat anti-mouse IgG-AP secondary (Sigma), 1:3000.",
            "startOffset": 65657,
            "title": "ELISA"
        },
        {
            "endOffset": 72119,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Three days later, DFA was performed (Table 1a).",
            "startOffset": 72072,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 69955,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Sera were taken from individual mice (five per group) and analyzed for Pvs25-FhCMB-specific responses.",
            "startOffset": 69853,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 67430,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Reductions in intensity and prevalence were assessed with respect to the relevant controls.",
            "startOffset": 67339,
            "title": "DMFA"
        },
        {
            "endOffset": 79362,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Significant differences in antibody titers or TB efficacy were not recorded when using Alhydrogel or Abisco-100 as an adjuvant with Pvs25-FhCMB.",
            "startOffset": 79218,
            "title": "Discussion"
        },
        {
            "endOffset": 69601,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Both the non-reduced SDS-PAGE and the single SEC peak indicate Pfs25-FhCMB is a non-aggregated, monomeric protein.",
            "startOffset": 69487,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 77325,
            "parents": [],
            "secId": "sec0095",
            "sentence": "It is likely that other additional qualitative changes, such as isotype switching and affinity maturation, will significantly impact the biological activity and effector functions of any humoral immune response post-immunization.",
            "startOffset": 77096,
            "title": "Discussion"
        },
        {
            "endOffset": 68939,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Densitometry analysis of Western blots indicated that Pvs25-FhCMB was \u223c100% soluble.",
            "startOffset": 68855,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 78176,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Every Pvs25-derived immunization regime examined induced a TB response, with varying efficacy.",
            "startOffset": 78082,
            "title": "Discussion"
        },
        {
            "endOffset": 67569,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0450": {
                    "endOffset": 67568,
                    "startOffset": 67564
                }
            },
            "secId": "sec0055",
            "sentence": "The ability of harvested sera to recognize native Pvs25 was assessed by IFA on Pvs25DR3 ookinetes as described in Sinden et al. [41].",
            "startOffset": 67436,
            "title": "IFA"
        },
        {
            "endOffset": 80915,
            "parents": [],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 80914,
                    "startOffset": 80910
                }
            },
            "secId": "sec0095",
            "sentence": "Pvs25 produced using an experimental baculovirus expression system was shown to induce a strong TB effect of 83.8% (intensity) and 88.4% (prevalence) in DFA following i.m. immunization (mean control intensity of 2.16 oocysts/midgut) [19].",
            "startOffset": 80677,
            "title": "Discussion"
        },
        {
            "endOffset": 67338,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 67337,
                    "startOffset": 67333
                }
            },
            "secId": "sec0050",
            "sentence": "Mosquito maintenance and dissection were performed as described in Blagborough et al. [19].",
            "startOffset": 67247,
            "title": "DMFA"
        },
        {
            "endOffset": 61658,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0355": {
                    "endOffset": 61657,
                    "startOffset": 61650
                },
                "bib0380": {
                    "endOffset": 61657,
                    "startOffset": 61650
                }
            },
            "secId": "sec0015",
            "sentence": "Vector was introduced into Agrobacterium tumefaciens GV3101 by electroporation, and vacuum infiltrated into leaves of six-week-old hydroponically grown N. benthamiana as described previously [22,27].",
            "startOffset": 61459,
            "title": "Pvs25-FhCMB cloning and expression"
        },
        {
            "endOffset": 82701,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Crucially, this study also demonstrates that combining this with other vaccine platforms (e.g. adenoviral delivery) can elicit maximal potency.",
            "startOffset": 82558,
            "title": "Discussion"
        },
        {
            "endOffset": 62409,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "For Western blot, samples were blocked with I-Block (Applied Biosystems).",
            "startOffset": 62336,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 80676,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Immunization with the regimes outlined here can be compared to previously reported studies where the transgenic chimeric parasite Pvs25DR3 was used to determine in vivo potency of candidate TBVs.",
            "startOffset": 80481,
            "title": "Discussion"
        },
        {
            "endOffset": 70026,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "No antibody responses against Pvs25-FhCMB were detected in day 0 sera.",
            "startOffset": 69956,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 74493,
            "parents": [],
            "refoffsets": {
                "bib0390": {
                    "endOffset": 74492,
                    "startOffset": 74488
                }
            },
            "secId": "sec0095",
            "sentence": "We have previously reported on the production of Pfs25 variants in N. benthamiana [29].",
            "startOffset": 74406,
            "title": "Discussion"
        },
        {
            "endOffset": 62266,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0390": {
                    "endOffset": 62265,
                    "startOffset": 62258
                },
                "bib0395": {
                    "endOffset": 62265,
                    "startOffset": 62258
                }
            },
            "secId": "sec0020",
            "sentence": "LicKM was expressed as described previously [29,30].",
            "startOffset": 62214,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 73463,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0090",
            "sentence": "Serum collected from mice primed with Pvs25-ChAd63 and boosted with Pvs25-FhCMB/Abisco-100 (regime 4), was pooled and evaluated in DMFA.",
            "startOffset": 73327,
            "title": "Evaluation of ex vivo TB activity (DMFA)"
        },
        {
            "endOffset": 62213,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Eluted fraction was concentrated 10-fold by centrifugation (Centricon-70, 30 kDa MWCO) and aliquots were frozen at \u2264-60 \u00b0C.",
            "startOffset": 62090,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 61805,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "N. benthamiana plants expressing Pvs25-FhCMB were harvested at 6 dpi and stored at \u2264-60 \u00b0C.",
            "startOffset": 61714,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 69178,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "SDS-PAGE indicates a single prominent band at approximately 55 kDa (Fig. 1c).",
            "startOffset": 69101,
            "title": "Expression, purification and characterization of Pvs25-FhCMB"
        },
        {
            "endOffset": 56541,
            "parents": [],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 56540,
                    "startOffset": 56535
                },
                "bib0290": {
                    "endOffset": 56540,
                    "startOffset": 56535
                }
            },
            "secId": "sec0005",
            "sentence": "No licensed vaccine for malarial prophylaxis is currently available [8,9].",
            "startOffset": 56467,
            "title": "Introduction"
        },
        {
            "endOffset": 72882,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "The highest efficacy in terms of both intensity and prevalence was observed following immunization with Pvs25-ChAd63, boosted with Pvs25F3E-LicKM/Abisco-100 (regime 4), where a mean reduction in intensity/prevalence of 74.5%/68.3%, respectively was achieved.",
            "startOffset": 72624,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 59514,
            "parents": [],
            "refoffsets": {
                "bib0425": {
                    "endOffset": 59513,
                    "startOffset": 59506
                },
                "bib0430": {
                    "endOffset": 59513,
                    "startOffset": 59506
                }
            },
            "secId": "sec0005",
            "sentence": "Studies on vaccine candidates AMA1 and MSP have demonstrated that this regimen is safe and immunogenic [36,37].",
            "startOffset": 59403,
            "title": "Introduction"
        },
        {
            "endOffset": 75467,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Pvs25-FhCMB with Abisco-100 adjuvant; 2).",
            "startOffset": 75426,
            "title": "Discussion"
        },
        {
            "endOffset": 67246,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The mixture was placed in a membrane feeder, 37 \u00b0C and Anopheles dirus A mosquitoes (Bangkok colony, Armed Forces Research Institute of Medical Sciences) were allowed to feed for 30 min.",
            "startOffset": 67060,
            "title": "DMFA"
        },
        {
            "endOffset": 75705,
            "parents": [],
            "secId": "sec0095",
            "sentence": "A combination of adenoviral delivery (Pvs25-ChAd63) with a Pvs25-FhCMB recombinant protein boost.",
            "startOffset": 75608,
            "title": "Discussion"
        },
        {
            "endOffset": 81906,
            "parents": [],
            "secId": "sec0095",
            "sentence": "A 67% reduction in intensity and a 28% reduction in prevalence were reported.",
            "startOffset": 81829,
            "title": "Discussion"
        },
        {
            "endOffset": 58782,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Here, a Pvs25-LicKM fusion protein (Pvs25-FhCMB) was produced using N. benthamiana as an expression host.",
            "startOffset": 58677,
            "title": "Introduction"
        },
        {
            "endOffset": 64606,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "For vaccination with Alhydrogel, 10 doses (50 \u03bcL per mouse) were prepared by combining 85 \u03bcL of Alhydrogel\u2122 containing 850 \u03bcg of aluminium in Eppendorf tubes under aseptic conditions with 165 \u03bcL of TRIS buffer (20 mM Tris, pH 7.4, 0.9% NaCl).",
            "startOffset": 64364,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 64895,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "After 15 min, 250 \u03bcL of antigen solution was added to corresponding tubes, which were vortexed and incubated for 1 h. For Abisco-100\u2122 adjuvant, recombinant protein was mixed with adjuvant, vortexed for 10 s and injected immediately (5 \u03bcL Abisco-100 per mouse in total vaccination volume).",
            "startOffset": 64607,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 70220,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Analysis of responses following Pvs25-based immunization detected anti-Pvs25 antibody both pre- and post-boost for all regimes tested, with higher end-point titers detected post-boost (Fig. 3a).",
            "startOffset": 70026,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 82028,
            "parents": [],
            "secId": "sec0095",
            "sentence": "This translated to a 96% reduction in intensity and 78% reduction in prevalence at sera dilutions of one in five in SMFA.",
            "startOffset": 81907,
            "title": "Discussion"
        },
        {
            "endOffset": 79561,
            "parents": [],
            "secId": "sec0095",
            "sentence": "berghei TB activity.",
            "startOffset": 79541,
            "title": "Discussion"
        },
        {
            "endOffset": 81828,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Cohorts of mice were immunized with AdHu5/MVA Pfs25 in a heterologous prime boost regime, and subjected to DFA.",
            "startOffset": 81717,
            "title": "Discussion"
        },
        {
            "endOffset": 61052,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Pvs25 protein sequence corresponding to Ala23-Leu195 (NCBI accession XP_001608460) was codon optimized for plants expression (GeneArt\u00ae, Germany).",
            "startOffset": 60907,
            "title": "Pvs25-FhCMB cloning and expression"
        },
        {
            "endOffset": 62647,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Protein concentration of Pvs25-FhCMB was determined by UV\u2212vis spectrometry using the denaturing method of Edelhoch (1967) with the theoretical extinction coefficient of 73,960 M\u22121 cm\u22121.",
            "startOffset": 62462,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 68430,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0065",
            "sentence": "Parametric ELISA tests were assessed using t-test.",
            "startOffset": 68380,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 62756,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Analytical size exclusion chromatography was performed on a Zenix300 HPLC column (Sepax Technologies, Inc.).",
            "startOffset": 62648,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 63253,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0400": {
                    "endOffset": 63251,
                    "startOffset": 63241
                },
                "bib0435": {
                    "endOffset": 63251,
                    "startOffset": 63241
                },
                "bib0455": {
                    "endOffset": 63251,
                    "startOffset": 63241
                }
            },
            "secId": "sec0025",
            "sentence": "Recombinant ChAd63, MVA vaccines and controls were generated [31,38,42] .",
            "startOffset": 63180,
            "title": "Production of viral vector-based Pvs25 vaccines"
        },
        {
            "endOffset": 74627,
            "parents": [],
            "secId": "sec0095",
            "sentence": "In that study, the presence of N-linked glycans impaired the induction of TB activity by the recombinant non-fusion version of Pfs25.",
            "startOffset": 74494,
            "title": "Discussion"
        },
        {
            "endOffset": 59804,
            "parents": [],
            "secId": "sec0005",
            "sentence": "We show that immunization of mice with Pvs25-FhCMB elicited effective Pvs25-specific humoral immune responses and significant TB activity.",
            "startOffset": 59666,
            "title": "Introduction"
        },
        {
            "endOffset": 82557,
            "parents": [],
            "secId": "sec0095",
            "sentence": "The efficient plant-based production of Pvs25, generation of high titers and induction of a TB response demonstrates the capability of these approaches to produce anti-malarial TBVs.",
            "startOffset": 82375,
            "title": "Discussion"
        },
        {
            "endOffset": 62461,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Blots were developed using anti-4xHis mAb (Qiagen).",
            "startOffset": 62410,
            "title": "Pvs25-FhCMB protein purification and characterization"
        },
        {
            "endOffset": 70639,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "The lowest anti-Pvs25-FhCMB end-point titers were exhibited with regime 3 (Pvs25-ChAd63 + MVA).",
            "startOffset": 70544,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 71382,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "The lowest mean end-point titers were observed against serum from regime 2, whereas the highest was observed from regime 4; however, differences detected between end-point titers from all regimes were not statistically significant (p > 0.05).",
            "startOffset": 71140,
            "title": "Immunogenicity of Pvs25-FhCMB and induction of target-specific antibodies"
        },
        {
            "endOffset": 75295,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Similar to Pfs25, the Pvs25 sequence contains 22 cysteines, but unlike the Pfs25 sequence Pvs25 does not contain any putative N-linked glycosylation sites.",
            "startOffset": 75140,
            "title": "Discussion"
        },
        {
            "endOffset": 78658,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Substitution of MVA boost at 8 weeks with 50 \u03bcg of Pvs25-FhCMB plus Abisco-100 adjuvant not only increased the end-point anti-Pvs25 antibody titer (against both Pvs25-FhCMB and r-Pvs25), but also increased the efficacy of the regime, to a 74.5% reduction in intensity/68.3% reduction in infection prevalence.",
            "startOffset": 78350,
            "title": "Discussion"
        },
        {
            "endOffset": 59666,
            "parents": [],
            "refoffsets": {
                "bib0435": {
                    "endOffset": 59665,
                    "startOffset": 59655
                },
                "bib0440": {
                    "endOffset": 59665,
                    "startOffset": 59655
                },
                "bib0490": {
                    "endOffset": 59665,
                    "startOffset": 59655
                }
            },
            "secId": "sec0005",
            "sentence": "Previous experiments involving immunization of mice with adenovirus expressing Pfs25 or Pvs25 have led to antibodies exhibiting TB efficacy [38,39,49].",
            "startOffset": 59515,
            "title": "Introduction"
        },
        {
            "endOffset": 76839,
            "parents": [],
            "secId": "sec0095",
            "sentence": "However, when objectively comparing differences in responses, it should be noted that no significant difference could be detected between regimes.",
            "startOffset": 76693,
            "title": "Discussion"
        },
        {
            "endOffset": 74233,
            "parents": [],
            "refoffsets": {
                "bib0460": {
                    "endOffset": 74232,
                    "startOffset": 74228
                }
            },
            "secId": "sec0095",
            "sentence": "Both the WHO and the Malaria Eradication Research Agenda have previously set as a core goal for any malaria vaccine program the need to reduce transmission and morbidity [43].",
            "startOffset": 74058,
            "title": "Discussion"
        },
        {
            "endOffset": 56703,
            "parents": [],
            "refoffsets": {
                "bib0265": {
                    "endOffset": 56702,
                    "startOffset": 56699
                }
            },
            "secId": "sec0005",
            "sentence": "Chemotherapy is the only clinically available treatment for confirmed infection; however, recurring drug resistance reduces the efficiency of anti-malarials [4].",
            "startOffset": 56542,
            "title": "Introduction"
        },
        {
            "endOffset": 74753,
            "parents": [],
            "refoffsets": {
                "bib0395": {
                    "endOffset": 74752,
                    "startOffset": 74748
                }
            },
            "secId": "sec0095",
            "sentence": "To increase immunogenicity, Pfs25 lacking N-glycosylation sites was fused to modified lichenase carrier molecule, LicKM [30].",
            "startOffset": 74628,
            "title": "Discussion"
        },
        {
            "endOffset": 79540,
            "parents": [],
            "secId": "sec0095",
            "sentence": "None of the regimes generated a non-specific TB effect following challenge with P. berghei 2.34, suggesting a specific response against Pvs25, and a lack of non-specific anti-P.",
            "startOffset": 79363,
            "title": "Discussion"
        },
        {
            "endOffset": 63538,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0485": {
                    "endOffset": 63424,
                    "startOffset": 63420
                }
            },
            "secId": "sec0030",
            "sentence": "Pvs25 antigen sequence was codon optimized for expression in Homo sapiens, subcloned into modified pENTR4-LPTOS TM [48] plasmid between a tPA leader and an affinity sequence encoding a biotin-acceptor peptide and a hexahistidine tag.",
            "startOffset": 63305,
            "title": "Production of recombinant Pvs25 (r-Pvs25) protein"
        },
        {
            "endOffset": 72623,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Significant reduction in intensity was observed with regimes 1, 2 and 4, and significant reduction in prevalence was observed with all Pvs25-regimes.",
            "startOffset": 72474,
            "title": "Evaluation of in vivo TB activity (DFA)"
        },
        {
            "endOffset": 79217,
            "parents": [],
            "secId": "sec0095",
            "sentence": "When using Alhydrogel as adjuvant, a 56.58% reduction in intensity/56.82% reduction in prevalence was recorded.",
            "startOffset": 79106,
            "title": "Discussion"
        },
        {
            "endOffset": 65453,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "When initial immunization was performed with ChAd63, sera were collected at days 0, 56 and 70.",
            "startOffset": 65359,
            "title": "Immunization regimes"
        },
        {
            "endOffset": 81608,
            "parents": [],
            "refoffsets": {
                "bib0435": {
                    "endOffset": 81607,
                    "startOffset": 81603
                }
            },
            "secId": "sec0095",
            "sentence": "Additionally, a similar approach has previously been taken to examine the efficacy of adenoviral anti-Pfs25 (P. falciparum homolog of Pvs25) vaccines [38].",
            "startOffset": 81453,
            "title": "Discussion"
        },
        {
            "endOffset": 76529,
            "parents": [],
            "secId": "sec0095",
            "sentence": "Recognizing that ELISAs against the Pvs25-FhCMB recombinant protein included significant responses to LicKM (Fig. 3a outlines responses to Pvs25-FhCMB, comprising LickM), we examined responses against Pvs25 specifically (Fig. 3b).",
            "startOffset": 76299,
            "title": "Discussion"
        },
        {
            "endOffset": 82810,
            "parents": [],
            "secId": "sec0100",
            "sentence": "The authors are not aware of any conflicts of interest arising from this work.",
            "startOffset": 82732,
            "title": "Conflicts of interest statement"
        },
        {
            "endOffset": 68205,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0065",
            "sentence": "Statistical analysis was performed using Graphpad Prism.",
            "startOffset": 68149,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 73850,
            "parents": [
                {
                    "id": "sec0070",
                    "title": "Results"
                }
            ],
            "secId": "sec0090",
            "sentence": "Over two replicate experiments, an overall 85.3% reduction in infection intensity and a 25.6% reduction in prevalence were observed.",
            "startOffset": 73718,
            "title": "Evaluation of ex vivo TB activity (DMFA)"
        },
        {
            "endOffset": 82374,
            "parents": [],
            "secId": "sec0095",
            "sentence": "This study gives a clear indication as to the value of Nicotiana and adenoviral-derived immunogens to induce a TB response.",
            "startOffset": 82251,
            "title": "Discussion"
        },
        {
            "endOffset": 58619,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In mice and rabbits, fusion and non-fusion versions of plant-produced Pfs25 elicited high titers of anti-Pfs25 antibodies when administered with Alhydrogel as an adjuvant.",
            "startOffset": 58448,
            "title": "Introduction"
        }
    ],
    "docId": "S0264410X16302900",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "andrew.blagborough@imperial.ac.uk",
                "first": "A. M.",
                "initial": "A.M.",
                "last": "Blagborough"
            },
            {
                "email": null,
                "first": "K.",
                "initial": "K.",
                "last": "Musiychuk"
            },
            {
                "email": null,
                "first": "H.",
                "initial": "H.",
                "last": "Bi"
            },
            {
                "email": null,
                "first": "R. M.",
                "initial": "R.M.",
                "last": "Jones"
            },
            {
                "email": null,
                "first": "J. A.",
                "initial": "J.A.",
                "last": "Chichester"
            },
            {
                "email": null,
                "first": "S.",
                "initial": "S.",
                "last": "Streatfield"
            },
            {
                "email": null,
                "first": "K. A.",
                "initial": "K.A.",
                "last": "Sala"
            },
            {
                "email": null,
                "first": "S. E.",
                "initial": "S.E.",
                "last": "Zakutansky"
            },
            {
                "email": null,
                "first": "L. M.",
                "initial": "L.M.",
                "last": "Upton"
            },
            {
                "email": null,
                "first": "R. E.",
                "initial": "R.E.",
                "last": "Sinden"
            },
            {
                "email": null,
                "first": "I.",
                "initial": "I.",
                "last": "Brian"
            },
            {
                "email": null,
                "first": "S.",
                "initial": "S.",
                "last": "Biswas"
            },
            {
                "email": null,
                "first": "J.",
                "initial": "J.",
                "last": "Sattabonkot"
            },
            {
                "email": null,
                "first": "V.",
                "initial": "V.",
                "last": "Yusibov"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.05.007",
        "firstpage": "3252",
        "issn": "0264410X",
        "keywords": [
            "Malaria",
            "Plant-produced antigen",
            "Plasmodium",
            "Pvs25",
            "Subunit vaccine",
            "Transmission blocking vaccine"
        ],
        "lastpage": "3259",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax"
    }
}